Rare APOA5 promoter variants associated with paradoxical HDL cholesterol decrease in response to fenofibric acid therapy.
about
Rare LPL gene variants attenuate triglyceride reduction and HDL cholesterol increase in response to fenofibric acid therapy in individuals with mixed dyslipidemiaDifferential Lipid Response to Statins Is Associated With Variants in the BUD13-APOA5 Gene Region.Pharmacogenomics, lipid disorders, and treatment options.Pharmacogenetics of Lipid-Lowering Agents: Precision or Indecision Medicine?
P2860
Rare APOA5 promoter variants associated with paradoxical HDL cholesterol decrease in response to fenofibric acid therapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Rare APOA5 promoter variants a ...... se to fenofibric acid therapy.
@en
type
label
Rare APOA5 promoter variants a ...... se to fenofibric acid therapy.
@en
prefLabel
Rare APOA5 promoter variants a ...... se to fenofibric acid therapy.
@en
P2093
P2860
P50
P356
P1476
Rare APOA5 promoter variants a ...... se to fenofibric acid therapy.
@en
P2093
Ariel Brautbar
Christie M Ballantyne
Fengju Chen
Maja Barbalic
Steve Scherer
P2860
P304
P356
10.1194/JLR.M034132
P577
2013-04-30T00:00:00Z